文献速递乳腺乳腺X线

人工智能在乳腺X线摄影中的临床应用:一项前瞻性研究的启示

Clinical Application of AI in Mammography: Insights from a Prospective Study.
PubMed 文献 · Acad Radiol · 2025-06-02

这项单中心前瞻性研究纳入1063例接受诊断或筛查乳腺X线摄影的患者,比较独立AI软件(风险评分>30.44为阳性)与5名不同经验放射科医生按第五版BI-RADS评估的表现。AI检出82.75%(24/29)的癌症,医生多数投票阳性时检出89.65%(26/29);多数投票AUC为94.7%(95%CI: 91.1-98.3),AI为94.4%(95%CI: 88.5-100),两者无统计学显著差异(p=0.79)。

要点

  • AI独立评分>30.44为阳性,检出82.75%(24/29)的癌症。
  • 医生多数投票(BI-RADS 0、4、5)检出89.65%(26/29)的癌症。
  • AI与医生多数投票的AUC无统计学显著差异(p=0.79)。

核心结论

  • 在诊断环境中,AI算法可作为有效的计算机辅助诊断系统,辅助乳腺癌检出并减少阅片者间变异。

研究设计与样本

  • 单中心前瞻性研究,纳入1063例接受诊断或筛查乳腺X线摄影的患者,共评估2126幅乳腺图像;5名不同经验水平的放射科医生按第五版BI-RADS词典评估,独立AI软件给出0-100风险评分(>30.44为阳性);以组织病理学和两年随访确立金标准。

诊断标准与关键数值

  • AI阳性阈值定义为风险评分>30.44;医生多数投票阳性定义为BI-RADS 0、4和5。

临床应用与阅片要点

  • AI独立评分>30.44为阳性,检出82.75%(24/29)的癌症。
  • 医生多数投票阳性时检出89.65%(26/29)的癌症。
  • 对AI标记图像进行二次阅片评估的AUC为94.8%(95%CI: 91.2-98.3),与初始评估有统计学显著差异(p=0.015),但与AI无统计学显著差异(p=0.74)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: This prospective study evaluated the performance of AI in a diagnostic clinic setting, comparing its effectiveness with radiologists of varying experience.

MATERIALS AND METHODS: The study was conducted at a single center and included 1063 patients undergoing diagnostic or screening mammography. Five radiologists with different experience levels assessed the images using the fifth edition of the BI-RADS lexicon. Standalone AI software assigned risk scores (0-100), with scores above 30.44 considered positive. AI risk assessments were compared with radiologists' BI-RADS scores. Radiologists also re-evaluated AI-positive mammograms as a second look. Ground truth was established through histopathology and two years of follow-up.

RESULTS: Right and left breasts were analyzed separately, and 2126 mammography images were evaluated from 1063 women. A total of 29 cancers were diagnosed in 28 women. Among all examinations, 2.44% (52/2126) were positive, of which 46.15% (24/52) were true positive. Standalone AI detected 82.75% (24/29) of cancers, and the majority voting of radiologists scored positive (BI-RADS 0,4 and 5) in 8% (172/2126) where 89.65% (26/29) of cancers were detected. The AUC score of majority voting was 94.7% (95% CI: 91.1-98.3), and AI was 94.4% (95% CI: 88.5-100). AI was statistically not significantly different than (p=0.79) AUC of the majority voting. The re-evaluation assessment of AI-flagged images achieved an AUC of 94.8% (95% CI: 91.2-98.3), significantly different from the initial evaluation (p=0.015). However, it was not significantly different from AI (p=0.74).

CONCLUSION: AI algorithms in diagnostic settings can serve as effective CAD systems, aiding in breast cancer detection and reducing inter-reader variability.

DATA AVAILABILITY: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Yilmaz E, Seker ME, Guldogan N, et al. Clinical Application of AI in Mammography: Insights from a Prospective Study. Acad Radiol. 2025. PMID: 40461327. doi:10.1016/j.acra.2025.05.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。